The health secretary, Vice President JD Vance and other top officials addressed a conference sponsored by corporations, including A.I. companies and others with business before the government.

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.

They'll emphasize overlapping interests with the movement.

Big shifts in health care policy could emerge depending on who wins the midterms, affecting hospitals and pharma companies.

Dr. Heidi Overton was pressed on the president’s false statements about the measles vaccine and his intervention in tobacco policy.

Congress is considering linking doctor payment rates to medical inflation under the proposed Patients First Act.

Democrats and Republicans in Congress opposed the creation of a commission with the power to veto federal research awards.

The use of artificial intelligence by hospitals and health insurers is escalating their longstanding feud over paying for medical care.

The agency led by Dr. Mehmet Oz is proposing an end to weekly tracking of respiratory infections at the facilities where thousands of elderly residents died in the pandemic.

The tax cuts in President Trump’s signature achievement were the Republicans’ answer to voters’ economic struggles, but its health care and food assistance cuts are taking a toll.

President Donald Trump’s tax and spending package threatens to remove millions of people from health insurance. Here’s a look at how Medicaid enrollees in New York could be affected.

Millions who use online pharmacies from Canada and other countries could get cut off in October.

Like many Americans, Joshua and Ashley Durham saw their health insurance premiums rise by hundreds of dollars a month this year. Despite being healthcare practitioners all too aware of the risks, they...

Anxiety over health care costs is driving a new brand of populism and talk about taking on health industries.

As the oldest baby boomers turn 80, researchers worry there won’t be enough room in nursing facilities for a rapidly graying nation.

Federal officials are drafting an executive order that would place grants under review by an outside panel, the latest effort to redirect billions of dollars in research spending.

Ahead of the midterm elections, the president said that all states had opted in to an effort to align Medicaid’s prices for medicines with those in other wealthy countries.

This year has become the deadliest year for measles in the United States since the virus was declared eliminated in 2000.

Democrats are mapping out their post-election strategy, and see health care probes as a winning issue.

Rep. Pramila Jayapal is pushing Democrats to mark up her bill if they win a majority in November.

The 40-year-old woman was unvaccinated, according to the coroner. Measles cases in the U.S. are at their highest level in three decades.

Hospitals warn there will be consequences for patient access.

Cardiologists are struggling to figure out why a drug that should have prevented heart attacks didn’t work at all.

Democrats say the Trump administration's plan to collect patients' medical data violates privacy and will discourage people from seeking medical care.

A new industry report shows 90% of major brand-name biologic drugs losing exclusivity over the next decade have no low-cost competitors in development.

The New York City health department is investigating the apparent cluster, and the city said it would check nearby cooling towers. An earlier outbreak in Manhattan killed 11 people.

This fact sheet presents five steps for helping someone having thoughts of suicide: Ask, Be There, Help Keep Them Safe, Help Them Connect, and Follow Up.

CEOs of the biggest AI companies have predicted the technology will “eliminate most cancer” and “improve treatment of most other ailments.” But nowhere better illustrates the challenge facing AI than ...

Employers added 162,000 jobs and unemployment held at 4.1 percent last month, signs of a stability that contrasted with high inflation weighing on households and markets.

As Dr. Anthony Fauci has faced public scrutiny from congressional Republicans, the D.O.J. has pursued a quieter and more expansive effort against a wider circle of researchers.

A new U.S. survey anticipates an average increase of 11 percent unless benefits are cut, the highest rate in decades. Other findings also predict a sharp rise.

President Trump on Monday announced the next round of pricing deals with drugmakers, with nine new companies making such agreements.

Doctors are hopeful for a quieter fall and winter than in 2025.